These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28761055)

  • 21. Disruption of S2-M4 linker coupling reveals novel subunit-specific contributions to N-methyl-d-aspartate receptor function and ethanol sensitivity.
    Hughes BA; Woodward JJ
    Neuropharmacology; 2016 Jun; 105():96-105. PubMed ID: 26577016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetic contributions to gating by interactions unique to N-methyl-D-aspartate (NMDA) receptors.
    Borschel WF; Cummings KA; Tindell LK; Popescu GK
    J Biol Chem; 2015 Oct; 290(44):26846-55. PubMed ID: 26370091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel family of negative and positive allosteric modulators of NMDA receptors.
    Costa BM; Irvine MW; Fang G; Eaves RJ; Mayo-Martin MB; Skifter DA; Jane DE; Monaghan DT
    J Pharmacol Exp Ther; 2010 Dec; 335(3):614-21. PubMed ID: 20858708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of ArgTX-636 in the NMDA receptor ion channel.
    Poulsen MH; Andersen J; Christensen R; Hansen KB; Traynelis SF; Strømgaard K; Kristensen AS
    J Mol Biol; 2015 Jan; 427(1):176-89. PubMed ID: 24862283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology.
    Ogden KK; Chen W; Swanger SA; McDaniel MJ; Fan LZ; Hu C; Tankovic A; Kusumoto H; Kosobucki GJ; Schulien AJ; Su Z; Pecha J; Bhattacharya S; Petrovski S; Cohen AE; Aizenman E; Traynelis SF; Yuan H
    PLoS Genet; 2017 Jan; 13(1):e1006536. PubMed ID: 28095420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-channel properties of N-methyl-D-aspartate receptors containing chimaeric GluN2A/GluN2D subunits.
    O'Leary T; Wyllie DJ
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1347-54. PubMed ID: 19909274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gating mechanism and a modulatory niche of human GluN1-GluN2A NMDA receptors.
    Wang H; Lv S; Stroebel D; Zhang J; Pan Y; Huang X; Zhang X; Paoletti P; Zhu S
    Neuron; 2021 Aug; 109(15):2443-2456.e5. PubMed ID: 34186027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Negative Allosteric Modulator EU1794-4 Reduces Single-Channel Conductance and Ca
    Perszyk RE; Zheng Z; Banke TG; Zhang J; Xie L; McDaniel MJ; Katzman BM; Pelly SC; Yuan H; Liotta DC; Traynelis SF
    Mol Pharmacol; 2021 May; 99(5):399-411. PubMed ID: 33688039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of cross-cleft contacts in NMDA receptor gating.
    Paganelli MA; Kussius CL; Popescu GK
    PLoS One; 2013; 8(11):e80953. PubMed ID: 24278352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chimeric Glutamate Receptor Subunits Reveal the Transmembrane Domain Is Sufficient for NMDA Receptor Pore Properties but Some Positive Allosteric Modulators Require Additional Domains.
    Wilding TJ; Lopez MN; Huettner JE
    J Neurosci; 2016 Aug; 36(34):8815-25. PubMed ID: 27559165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ligand binding domain interface: A tipping point for pharmacological agents binding with GluN1/2A subunit containing NMDA receptors.
    Bledsoe D; Vacca B; Laube B; Klein BG; Costa B
    Eur J Pharmacol; 2019 Feb; 844():216-224. PubMed ID: 30553788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator.
    Khatri A; Burger PB; Swanger SA; Hansen KB; Zimmerman S; Karakas E; Liotta DC; Furukawa H; Snyder JP; Traynelis SF
    Mol Pharmacol; 2014 Nov; 86(5):548-60. PubMed ID: 25205677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular dynamics study-based mechanism of nefiracetam-induced NMDA receptor potentiation.
    Omotuyi OI; Ueda H
    Comput Biol Chem; 2015 Apr; 55():14-22. PubMed ID: 25659913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct functional and pharmacological properties of Triheteromeric GluN1/GluN2A/GluN2B NMDA receptors.
    Hansen KB; Ogden KK; Yuan H; Traynelis SF
    Neuron; 2014 Mar; 81(5):1084-1096. PubMed ID: 24607230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A structurally derived model of subunit-dependent NMDA receptor function.
    Gibb AJ; Ogden KK; McDaniel MJ; Vance KM; Kell SA; Butch C; Burger P; Liotta DC; Traynelis SF
    J Physiol; 2018 Sep; 596(17):4057-4089. PubMed ID: 29917241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct GluN1 and GluN2 Structural Determinants for Subunit-Selective Positive Allosteric Modulation of
    Strong KL; Epplin MP; Ogden KK; Burger PB; Kaiser TM; Wilding TJ; Kusumoto H; Camp CR; Shaulsky G; Bhattacharya S; Perszyk RE; Menaldino DS; McDaniel MJ; Zhang J; Le P; Banke TG; Hansen KB; Huettner JE; Liotta DC; Traynelis SF
    ACS Chem Neurosci; 2021 Jan; 12(1):79-98. PubMed ID: 33326224
    [No Abstract]   [Full Text] [Related]  

  • 37. Positive Allosteric Modulation as a Potential Therapeutic Strategy in Anti-NMDA Receptor Encephalitis.
    Warikoo N; Brunwasser SJ; Benz A; Shu HJ; Paul SM; Lewis M; Doherty J; Quirk M; Piccio L; Zorumski CF; Day GS; Mennerick S
    J Neurosci; 2018 Mar; 38(13):3218-3229. PubMed ID: 29476014
    [No Abstract]   [Full Text] [Related]  

  • 38. GluN1 splice variant control of GluN1/GluN2D NMDA receptors.
    Vance KM; Hansen KB; Traynelis SF
    J Physiol; 2012 Aug; 590(16):3857-75. PubMed ID: 22641781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Site of Action of Brain Neurosteroid Pregnenolone Sulfate at the N-Methyl-D-Aspartate Receptor.
    Hrcka Krausova B; Kysilov B; Cerny J; Vyklicky V; Smejkalova T; Ladislav M; Balik A; Korinek M; Chodounska H; Kudova E; Vyklicky L
    J Neurosci; 2020 Jul; 40(31):5922-5936. PubMed ID: 32611707
    [No Abstract]   [Full Text] [Related]  

  • 40. Conformational analysis of NMDA receptor GluN1, GluN2, and GluN3 ligand-binding domains reveals subtype-specific characteristics.
    Yao Y; Belcher J; Berger AJ; Mayer ML; Lau AY
    Structure; 2013 Oct; 21(10):1788-99. PubMed ID: 23972471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.